ATRA

Atara Biotherapeutics, Inc.

A biotechnology company making "off-the-shelf" T-cell therapies that treat cancer, autoimmune diseases, and viral infections, using cells donated by healthy strangers rather than a patient's own cells—so treatment can be delivered in days instead of weeks. Founded in 2012 by Dr. Isaac Ciechanover, the company is named in memory of his mother, Atara, who died of ovarian cancer; the name means "crown" in Hebrew. The technology grew out of research at Memorial Sloan Kettering Cancer Center and Australia's QIMR Berghofer Medical Research Institute.

CUSIP: 046513107HealthcareUS2 holders1 derivative reporter

Ownership Activity Financials Filings

ATRA

ATRA

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Financial Statements and Exhibits

Other Events

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Results of Operations and Financial Condition

Other Events